Aurinia Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '25 Dec 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	1,820	1,242	1,168	574	2,608	1,431	Upgrade
Market Cap Growth	53.55%	6.33%	103.33%	-77.97%	82.23%	-27.33%	Upgrade
Enterprise Value	1,587	990	947	230	2,364	1,117	Upgrade
Last Close Price	13.76	8.62	8.19	3.43	19.77	11.10	Upgrade
PE Ratio	27.44	223.53	-	-	-	-	Upgrade
PS Ratio	8.04	5.47	7.36	4.58	65.03	34.93	Upgrade
PB Ratio	5.84	3.41	3.42	1.51	6.19	4.29	Upgrade
P/TBV Ratio	5.90	3.45	3.46	1.54	6.30	4.39	Upgrade
P/FCF Ratio	17.85	29.15	-	-	-	-	Upgrade
P/OCF Ratio	17.78	28.97	-	-	-	-	Upgrade
EV/Sales Ratio	7.00	4.36	5.97	1.84	58.94	27.27	Upgrade
EV/EBITDA Ratio	18.35	32.08	-	-	-	-	Upgrade
EV/EBIT Ratio	22.93	81.91	-	-	-	-	Upgrade
EV/FCF Ratio	15.57	23.25	-	-	-	-	Upgrade
Debt / Equity Ratio	0.21	0.21	0.26	0.02	0.02	0.02	Upgrade
Debt / EBITDA Ratio	0.77	2.42	-	-	-	-	Upgrade
Debt / FCF Ratio	0.65	1.80	-	-	-	-	Upgrade
Asset Turnover	0.49	0.43	0.35	0.26	0.09	0.13	Upgrade
Inventory Turnover	1.26	1.24	1.98	2.30	3.14	-	Upgrade
Quick Ratio	5.02	4.05	4.86	8.76	11.84	12.45	Upgrade
Current Ratio	5.76	4.57	5.50	9.60	12.63	13.11	Upgrade
Return on Equity (ROE)	20.65%	1.52%	-19.92%	-24.46%	-40.81%	-29.07%	Upgrade
Return on Assets (ROA)	9.41%	1.42%	-10.53%	-13.74%	-22.43%	-16.54%	Upgrade
Return on Capital (ROIC)	11.02%	1.68%	-12.06%	-15.46%	-24.99%	-18.24%	Upgrade
Return on Capital Employed (ROCE)	18.00%	2.80%	-18.20%	-26.20%	-36.00%	-24.20%	Upgrade
Earnings Yield	3.64%	0.45%	-6.04%	-17.62%	-6.10%	-5.87%	Upgrade
FCF Yield	5.60%	3.43%	-2.65%	-13.00%	-5.33%	-4.32%	Upgrade
Buyback Yield / Dilution	1.24%	-2.07%	-0.93%	-9.70%	-9.20%	-27.36%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.